The poll did not include older respondents whosepotentially frail condition would

The poll did not include older respondents whosepotentially frail condition would not allow them to participate in a telephoneinterview. Therefore, the responses from the centenarians should be interpretedas being indicative (not statistically representative) of the views of healthyand articulate Americans in this age range. GfK Roper also conducted a total of 1,036 online interviews between April 13 andApril 22, 2009, with U.S. residents age 20-22 who expect to graduate from afour-year college or university in 2009. About Evercare by UnitedHealthcareEvercare by UnitedHealthcare is one of the largest coordinators of health carefocused on helping individuals living with disabilities, long-term or advancedillness. Evercare serves people through Medicare special needs plans, hospicecare, and caregiver support programs.

Evercare’s integrated care model deliverspersonalized health care services that help people stay healthy and independentin the most appropriate setting of their choice. For more information aboutEvercare visit Note to Editors: For the full report of the 2009 Evercare 100 100 Survey and the2008, 2007, and 2006 surveys, visit AboutEvercare .Evercare Contact:Jon Stone, 952-931-5491Mobile: Copyright Business Wire 2009. Funding Helps Provider of Innovative Wet Deposition Processes forThrough-Silicon Via 3D-Packaging Meet Continuing Growth in DemandMASSY, France–(Business Wire)–Alchimer S.A., a leading provider of cost-saving wet deposition processes forinterconnections in advanced 3D-packaging applications, announced today that ithas raised an additional $10 million in new financing to expand customer-supportprograms and pursue new IP development. Alchimer`s D round of funding includes both previous and new investors,including AGF, CEA Investissement and Emertec Gestion. “We expect Alchimer to make a significant contribution to 3D-packagingtechnology, which will play an important role in the development ofnext-generation devices,” said Jean-Philippe Stefanini, general partner ofGrenoble, France-based Emertec Gestion. “Alchimer is an ideal fit for ourportfolio, and we have great confidence in its experienced management team.” “The continued support of investors, especially in this difficult economicenvironment, is a solid endorsement of Alchimer`s innovative technology,” saidAlchimer CEO Steve Lerner. “It also underscores the impact of Alchimer`selectrografting technology in enabling the emerging 3D market through processenhancement and cost reduction.” Alchimer recently announced an enhancement of its eG ViaCoat process for thecopper seed metallization of through-silicon vias(TSVs), which are used tocreate interconnections in advanced 3D-packaging applications.

These structuresare typically very narrow in comparison to their depth; this high aspect ratiocreates a number of challenges to the deposition of uniform films. The eGViaCoat process uses chemicals to deposit these films at levels of uniformitythat meet or exceed standard industry quality metrics. In addition to having anumber of process advantages, this “wet” approach allows the eG ViaCoat to beimplemented on legacy plating equipment without retrofits or modifications. In further evidence of the company`s increasing acceptance as a low-costalternative for TSV copper seed and related films, Alchimer announced that ithas signed an agreement with Nagase & Co. Ltd., a Tokyo-basedtechnology-marketing company with an extensive background in chemicals, plasticsand electronics. Nagase will help Alchimer meet rapidly increasing demand fromkey Japanese customers.